Lam, Suk Wai http://orcid.org/0000-0001-9782-5938
Silva, Tulio M.
Traast-Kooistra, Jolanda
Bruijn, Inge Briaire-de
van den Akker, Brendy
Bakker, Pauline A. C.
Lansu, Jules http://orcid.org/0000-0003-1396-1647
Haas, Rick L. M. http://orcid.org/0000-0003-4834-4331
Bovée, Judith V. M. G. http://orcid.org/0000-0003-1155-0481
Article History
Received: 14 June 2023
Revised: 27 July 2023
Accepted: 28 July 2023
First Online: 12 August 2023
Declarations
: All patients included in the DOREMY clinical trial provided written informed consent before enrollment. The trial protocol and all amendments to it were approved by the institutional review board or research ethics committee of each of the 9 participating sarcoma centers. All samples are coded according to the Dutch code of proper secondary use of human material as accorded by the Dutch society of pathology (Federa).
: The authors declare no competing interests.